Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-OX in Refractory Metastatic Colorectal Cancer
NCT04294264Phase 2Active, not recruiting
- Sponsor
- Rutgers University
- Start
- Feb 2019
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trifluridine + tipiracil in colorectal cancer (CRC), sponsored by Rutgers University. Started Feb 2019; status: active, not recruiting.
02
Drugs
trifluridine + tipiracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04294264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04294264.